 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Nobel Laboratory |
| Street 1: | Hakim Nezami Junaction |
| Street 2: | |
| City: | Isfahan |
| Province: | Isfahan |
| Post Code: | 8175999761 |
| Country: | Iran (Islamic Republic of) |
| Phone: | 00983136246204 |
| Organization Email: | Fatemi_lab@yahoo.com |
| Web Site: | http://www.nobellab.com/ |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Partnership |
| Organization Type - Secondary: | National Stop TB Partnership |
| Organization Description: | |
| 1.The Nobel laboratory in Isfahan is one of the most equipped laboratories in Iran. The laboratory has a space of over 5,000 square meters and has 227 experienced staff. We provide more than 500,000 patients annually. The Nobel Laboratory aims to provide laboratory services using the most advanced technologies and equipment in cooperation with its well-trained and dedicated staff in an intimate and scientific environment. Providing the most accurate results at the earliest time, launching new specialized tests and collaborating, and helping other laboratories and clinics provide other laboratory services. The Nobel laboratory is working to provide new laboratory information to physicians and colleagues, as appropriate, so that more accurate testing can be done. 2. Neighborhood of Iran with the two countries of Afghanistan and Pakistan, which is among the 22 countries of the world's High Burden, as well as Iraq (with its recent years of crisis) and the newly independent states of the north (with a high prevalence of multi-drug resistant tuberculosis) He warns us about the disease more than before. A national study conducted in 2003 indicated that the median total delay in diagnosis and treatment of patients with positive sputum pulmonary tuberculosis in Iran was 92 days (with an average of 10 + 120 days), and the median late-onset of patient and physician diagnosis was 20 (with a mean 6 + 44 days) and 46 days (with an average of 76+ days). Therefore, the physicians share the diagnosis delays far more than the share of patients. Therefore, in order to control tuberculosis in the country, interventional interventions and control programs should focus on reducing the delay The doctor focuses on the diagnosis. Now, if we know that in a recent study in Iran, 67% of patients with positive sputum-positive pulmonary TB in the country, with the onset of tuberculosis, have indicated the first selected treatment unit for their referral to the private clinic, the importance and necessity of involving |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Delivery of health services and care Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | Iran (Islamic Republic of) |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The Nobel laboratory is in contact with the regional tuberculosis laboratory in Isfahan province. | |
Geographical Reach | |
| Which country is your headquarters located in: | Iran (Islamic Republic of) |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Iran (Islamic Republic of) |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Establishing training classes based on rapid diagnosis of tuberculosis, publishing and publishing educational posters on the prevention of tuberculosis, organizing the World Tuberculosis Day, establishing appropriate educational infrastructure for the development of community awareness. Drug-Resistant TB: Use of diagnostic methods approved by the World Health Organization to diagnose drug-resistant tuberculosis TB-HIV: Extend the use of the World Health Organization's guidelines for the diagnosis and treatment of TB patients infected with HIV Laboratory Strengthening: The Nobel laboratory is currently using XPERT MTB / RIf It uses molecular diagnostics. We hope that in the near future, we can use the lThe BD BACTEC™ MGIT™ automated mycobacterial detection system for mycobacterial liquid culture and susceptibility testing. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | March 3, 2018 |
| Last updated: | March 3, 2018 |